ACE2 and breast cancer: In breast cancer, angiotensin-converting enzyme 2 inhibited endothelial cells proliferation, tube formation, and migration through the phosphorylation of VEGFR2, MEK1/2, and ERK1/2 in HUVECs through the downregulation of VEGFA in breast cancer cells [38].